Mobile

A Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of the Addition of MK-0431 Compared With Sulfonylurea Therapy in Patients With Type 2 Diabetes With Inadequate Glycemi...

Update Il y a 5 ans
Reference: EUCTR2004-002159-16

A Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of the Addition of MK-0431 Compared With Sulfonylurea Therapy in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin Monotherapy

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

Main objective : In patients with type 2 diabetes mellitus with inadequate glycemic control on metformin therapy at a dose of at least 1500 mg/day: (1) After 52 weeks, to assess the effect of the addition of MK-0431 compared with glipizide on HbA1C; (2) To assess the safety and the tolerability of MK-0431 compared with glipizide.

Inclusion criteria

  • Type 2 diabetes mellitus

Links